Effect of intraocular injection of conbercept in the treatment of central serous chorioretinopathy
Objective To retrospectively analyze the effect of intraocular injection of conbercept in the treatment of central serous chorioretinopathy(CSC).Methods Forty patients(40 eyes)with CSC admitted from January to December 2022 were selected as the research objects.According to different treatment methods,the patients were divided into control group(fundus micropulse laser treatment)and observation group(intraocular injection of conbercept treatment),with 20 cases in each group.The therapeutic effects of the two groups were compared.Results At 1 week,1 month and 3 months after treatment,the best corrected visual acuity(BCVA)of the observation group was higher than that before treatment(P＜0.05);at 1 week,1 month and 3 months after treatment,the BCVA of the observation group was higher than that of the control group(P＜0.05);at 3 months after treatment,the BCVA of the control group was higher than that before treatment(P＜0.05).At 1 week,1 month and 3 months after treatment,the central retinal thickness(CRT)and subretinal fluid(SRF)height of the two groups were lower than those before treatment,and those of the observation group were lower than the control group(P＜0.05).Conclusion Intraocular injection of conbercept can be considered as one of the treatment options for CSC patients.
万方数据
维普
